First, we analyzed the mRNA levels of AURKB in prostate adenocarcinoma patients (46) and breast invasive ductal carcinoma patients (47) with low mRNA levels of BRCA2 from cBioPortal (48). The gene discussed is BRCA2; the disease is prostate adenocarcinoma.